Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burnout, Professional | 1 | 2023 | 128 | 0.710 |
Why?
|
| Extracellular Vesicles | 3 | 2020 | 54 | 0.330 |
Why?
|
| Radiology, Interventional | 1 | 2023 | 35 | 0.200 |
Why?
|
| Radiologists | 1 | 2023 | 50 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 1989 | 460 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 5 | 1993 | 57 | 0.180 |
Why?
|
| Cell-Free Nucleic Acids | 2 | 2019 | 50 | 0.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 1008 | 0.170 |
Why?
|
| RNA | 3 | 2019 | 519 | 0.170 |
Why?
|
| Immunoglobulin Variable Region | 2 | 1991 | 50 | 0.170 |
Why?
|
| Thymus Gland | 5 | 1993 | 102 | 0.160 |
Why?
|
| Cell Communication | 1 | 2019 | 191 | 0.140 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 1775 | 0.130 |
Why?
|
| Endothelial Cells | 1 | 2020 | 508 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2020 | 335 | 0.120 |
Why?
|
| MicroRNAs | 2 | 2020 | 875 | 0.120 |
Why?
|
| Pandemics | 1 | 2023 | 1141 | 0.120 |
Why?
|
| Spine | 1 | 2016 | 139 | 0.120 |
Why?
|
| Epigenomics | 1 | 2016 | 174 | 0.120 |
Why?
|
| Glioma | 1 | 2020 | 480 | 0.120 |
Why?
|
| Transcription, Genetic | 8 | 2004 | 1381 | 0.110 |
Why?
|
| Health Status | 1 | 2016 | 382 | 0.110 |
Why?
|
| DNA-Binding Proteins | 5 | 2004 | 1893 | 0.110 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 3932 | 0.100 |
Why?
|
| Hypoxia | 2 | 2005 | 243 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 4 | 1992 | 1487 | 0.100 |
Why?
|
| T-Lymphocytes | 4 | 2004 | 1726 | 0.090 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 1991 | 1 | 0.090 |
Why?
|
| Immunoglobulin J-Chains | 1 | 1991 | 3 | 0.090 |
Why?
|
| RNA, Messenger | 7 | 2004 | 2539 | 0.090 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1991 | 10 | 0.090 |
Why?
|
| Base Sequence | 8 | 1994 | 2766 | 0.080 |
Why?
|
| Recombination, Genetic | 3 | 2005 | 418 | 0.080 |
Why?
|
| Immunoglobulin Joining Region | 1 | 1989 | 4 | 0.080 |
Why?
|
| Molecular Sequence Data | 8 | 1994 | 3592 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 1989 | 66 | 0.070 |
Why?
|
| Major Histocompatibility Complex | 1 | 1988 | 54 | 0.070 |
Why?
|
| Brain | 1 | 2020 | 3037 | 0.070 |
Why?
|
| Trans-Activators | 3 | 1997 | 674 | 0.070 |
Why?
|
| United States | 1 | 2023 | 11427 | 0.070 |
Why?
|
| Adult | 3 | 2023 | 30609 | 0.060 |
Why?
|
| Transcription Factors | 5 | 2004 | 2346 | 0.060 |
Why?
|
| Quality of Life | 1 | 2016 | 2031 | 0.060 |
Why?
|
| Mice | 12 | 2004 | 17704 | 0.060 |
Why?
|
| Cloning, Molecular | 3 | 1992 | 784 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 6 | 1994 | 1003 | 0.060 |
Why?
|
| DNA Repair | 2 | 2005 | 550 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 1713 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2004 | 1205 | 0.060 |
Why?
|
| DNA Restriction Enzymes | 1 | 2004 | 73 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 1933 | 0.050 |
Why?
|
| Humans | 11 | 2023 | 127585 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 54 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2586 | 0.050 |
Why?
|
| Galactose | 1 | 2004 | 53 | 0.050 |
Why?
|
| Male | 7 | 2023 | 62935 | 0.050 |
Why?
|
| Muscles | 1 | 2004 | 222 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 156 | 0.050 |
Why?
|
| Female | 6 | 2023 | 68803 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 435 | 0.050 |
Why?
|
| Animals | 14 | 2004 | 33242 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2889 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 323 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 1232 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 396 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 589 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2004 | 745 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2000 | 76 | 0.040 |
Why?
|
| Circulating MicroRNA | 1 | 2019 | 11 | 0.040 |
Why?
|
| Gene Expression | 3 | 1999 | 1494 | 0.040 |
Why?
|
| Knowledge Bases | 1 | 2019 | 38 | 0.040 |
Why?
|
| Body Fluids | 1 | 2019 | 46 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 235 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2000 | 243 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 322 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2004 | 2309 | 0.030 |
Why?
|
| Zinc Fingers | 2 | 1997 | 109 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 965 | 0.030 |
Why?
|
| Placental Lactogen | 1 | 1997 | 2 | 0.030 |
Why?
|
| Nervous System | 2 | 1995 | 119 | 0.030 |
Why?
|
| Algorithms | 1 | 2004 | 1638 | 0.030 |
Why?
|
| Africa | 1 | 2016 | 135 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 418 | 0.030 |
Why?
|
| Disease Progression | 2 | 2016 | 2127 | 0.030 |
Why?
|
| Trophoblasts | 1 | 1997 | 113 | 0.030 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 1993 | 6 | 0.030 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1995 | 8 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 426 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1992 | 86 | 0.030 |
Why?
|
| Transfection | 3 | 2005 | 955 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 1997 | 979 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 250 | 0.030 |
Why?
|
| Aging | 2 | 1992 | 1210 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2016 | 311 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 3506 | 0.030 |
Why?
|
| Gene Targeting | 1 | 1995 | 169 | 0.030 |
Why?
|
| Databases, Factual | 1 | 1999 | 1199 | 0.030 |
Why?
|
| Software | 1 | 2019 | 714 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 1995 | 119 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2016 | 345 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2016 | 475 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 667 | 0.030 |
Why?
|
| Cell Cycle | 2 | 2005 | 589 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 253 | 0.020 |
Why?
|
| Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 1992 | 1 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 630 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1992 | 31 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 3 | 1997 | 41 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 1989 | 292 | 0.020 |
Why?
|
| Point Mutation | 1 | 1992 | 335 | 0.020 |
Why?
|
| Genes | 2 | 1989 | 304 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1991 | 95 | 0.020 |
Why?
|
| Spleen | 2 | 1989 | 255 | 0.020 |
Why?
|
| Cells, Cultured | 4 | 2000 | 2921 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2016 | 1034 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 3262 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1995 | 965 | 0.020 |
Why?
|
| Biotechnology | 1 | 1989 | 56 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1991 | 1053 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1988 | 364 | 0.020 |
Why?
|
| Liver | 1 | 1995 | 1764 | 0.020 |
Why?
|
| Kidney | 1 | 1994 | 1284 | 0.020 |
Why?
|
| Cell Line | 2 | 1989 | 2571 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 4312 | 0.020 |
Why?
|
| GATA2 Transcription Factor | 2 | 1997 | 46 | 0.020 |
Why?
|
| Rad51 Recombinase | 1 | 2005 | 31 | 0.010 |
Why?
|
| Luciferases | 1 | 2005 | 127 | 0.010 |
Why?
|
| Cell Separation | 1 | 2005 | 221 | 0.010 |
Why?
|
| In Situ Hybridization | 2 | 1997 | 449 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2004 | 9 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2004 | 90 | 0.010 |
Why?
|
| DNA | 1 | 1989 | 1426 | 0.010 |
Why?
|
| Rats | 2 | 2000 | 3396 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 760 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2004 | 649 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 9714 | 0.010 |
Why?
|
| Iron | 1 | 2004 | 300 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2004 | 250 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2000 | 6 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2000 | 22 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 12596 | 0.010 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2000 | 32 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2000 | 98 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2000 | 235 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2000 | 237 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2000 | 231 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 1999 | 119 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 1206 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 17105 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 20183 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1999 | 685 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2000 | 579 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1997 | 35 | 0.010 |
Why?
|
| Prolactin | 1 | 1997 | 111 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 1125 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 1395 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2000 | 764 | 0.010 |
Why?
|
| Litter Size | 1 | 1995 | 24 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1995 | 75 | 0.010 |
Why?
|
| Craniofacial Dysostosis | 1 | 1995 | 21 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1997 | 289 | 0.010 |
Why?
|
| Fetal Death | 1 | 1995 | 119 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1997 | 338 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 2079 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1993 | 53 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 121 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 1598 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1995 | 447 | 0.010 |
Why?
|
| Cell Movement | 1 | 1997 | 855 | 0.010 |
Why?
|
| Placenta | 1 | 1997 | 519 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1993 | 588 | 0.010 |
Why?
|
| Neural Tube Defects | 1 | 1995 | 366 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1995 | 525 | 0.010 |
Why?
|
| Gestational Age | 1 | 1995 | 1207 | 0.010 |
Why?
|
| Genotype | 1 | 1995 | 2604 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1994 | 2281 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1989 | 141 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 2544 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 1995 | 3731 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1993 | 4516 | 0.000 |
Why?
|
| Mutation | 1 | 1997 | 5953 | 0.000 |
Why?
|
| Genetic Variation | 1 | 1989 | 1509 | 0.000 |
Why?
|